companydata.dkY-mAbs Therapeutics A/S: Financial statements 2017
CVR: 37053678
Y-mAbs Therapeutics A/S (CVR 37053678) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 13,194,221 and a net result of DKK -2,177,894. Equity amounted to DKK 808,159. The solvency ratio was 7.4%.
- Gross Profit
- 13,194,221 kr.
- Profit/Loss
- -2,177,894 kr.
- Equity
- 808,159 kr.
- Total Assets
- 10,941,368 kr.
Find more companies like Y-mAbs Therapeutics A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
Y-mAbs Therapeutics A/S has published its interim report for the period August 27, 2015 – December 31, 2016.
About Y-mAbs Therapeutics A/S
Y-mAbs Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Vincent Sainte-Catherine. The company is owned by Y-mAbs Therapeutics, Inc.. The company has 24 employees. In 2025, the company reported a gross profit of DKK 29,300,371 and a net result of DKK -38,461,598 compared with DKK -12,500,464 the year before. Equity amounted to DKK -163,651,844.